Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

Code · REGISTER · 2025-07-30 · Food and Drug Administration, HHS · Notices

Notices. Notice

291 words·~1 min read·/register/2025/07/30/2025-14345·

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 4164-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2025-N-0008] Arthritis Advisory Committee; Termination AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA or the Agency) is announcing the termination of the Agency's Arthritis Advisory Committee (Committee) by the Commissioner of Food and Drugs (Commissioner). The Commissioner has determined that it is not necessary to continue to maintain this Committee.
DATES: This Committee will terminate on the date of publication of this notice. FOR FURTHER INFORMATION CONTACT: Emily Helms Williams, Director, Advisory Committee Oversight and Management Staff, Office of the Chief Scientist, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 1, Rm. 3240, Silver Spring, MD 20993, 301-796-3381, *Emily.HelmsWilliams@fda.hhs.gov.* SUPPLEMENTARY INFORMATION: The Arthritis Advisory Committee was established on April 5, 1974 (39 FR 14737-14738), to advise the Commissioner or designee in discharging responsibilities as they relate to helping to ensure safe and effective drugs for human use in arthritic conditions, and as required, any other product for which FDA has regulatory responsibility.
This Committee has met infrequently in recent years, and FDA has determined that the effort and expense of maintaining the Committee is no longer justified. This Committee is therefore terminated, effective on July 30, 2025, in accordance with 21 CFR 14.55. This notice is issued under the Federal Advisory Committee Act of October 6, 1972 (Pub. L. 92-463) (5 U.S.C. 1001 *et seq.* ). Elsewhere in this issue of the **Federal Register,** FDA is publishing a final rule announcing the removal of the Arthritis Advisory Committee from the Agency's list of standing advisory committees.
Dated: July 25, 2025. Grace R. Graham, Deputy Commissioner for Policy, Legislation, and International Affairs. [FR Doc. 2025-14345 Filed 7-29-25; 8:45 am]
Connectionstraces to 2
1 reference not yet in our index
  • Pub. L. 92-463
Citation graph
cites case law
Notices
Notice
Pub. L.Pub. L. 92-463
Cites 3Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.